tirzepatide dose chart Dosing in Units: Master for All 4 Vial Sizes Zepbound® Tirzepatide Dosage Guide

Reference: Association Between GLP-1 Receptor Agonist Use and Epilepsy Risk in Type 2 Diabetes by Ching-Yang Cheng, Shih-Chang Lo, Chien-Ning Huang, Yi-Sun Yang, Yu-Hsun Wang and Edy Kornelius, 10 December 2025, Neurology

The study co-authors, Dr Cindy Lin and Dr Benjamin Liu, said: Our findings are significant in that they could change the paradigm of obesity management by suggesting early intervention with GLP-1 RAs could delay or prevent obesity-related cancer development. There could be multiple ways in which the drugs cut the risk of cancer not just by helping people to lose weight, they added

But losing the weight too rapidly can exacerbate the damage the body will not only break down fat stores for energy (the goal of weight-loss), but start to break down muscle tissue as well

Do I need to stay on weight loss medications forever